These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6103274)

  • 1. Dexamethasone suppression test identifies subtypes of depression which respond to different antidepressants.
    Brown WA; Haier RJ; Qualls CB
    Lancet; 1980 Apr; 1(8174):928-9. PubMed ID: 6103274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment?
    Brown WA; Qualls CB
    Psychiatry Res; 1981 Apr; 4(2):115-28. PubMed ID: 6939003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs)].
    Beresewicz M; Bidzińska E; Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):13-8. PubMed ID: 1687987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
    Amsterdam J; Brunswick D; Mendels J
    Am J Psychiatry; 1980 Jun; 137(6):653-62. PubMed ID: 6990798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype.
    Robbins DR; Alessi NE; Colfer MV
    J Affect Disord; 1989; 17(2):99-104. PubMed ID: 2527896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of the tricyclic-induced switch in bipolar manic-depression.
    Waters BG; Lapierre YD
    Am J Psychiatry; 1982 Feb; 139(2):245-6. PubMed ID: 6798886
    [No Abstract]   [Full Text] [Related]  

  • 10. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test.
    Kitamura Y; Araki H; Gomita Y
    Pharmacol Biochem Behav; 2002; 71(1-2):63-9. PubMed ID: 11812508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry and treatment strategies for depression.
    Garvey MJ
    J Fam Pract; 1980 Aug; 11(2):215-9. PubMed ID: 6106040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of imipramine and amitriptyline on the hypothalamic function in affective disorders.
    Horodnicki JM; Szakowski A; Wdowiak J
    Act Nerv Super (Praha); 1989 Apr; 31(1):27-9. PubMed ID: 2781995
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic administration of tricyclic antidepressants suppresses hypothalamo-pituitary-adrenocortical activity in male rats.
    Shimoda K; Yamada N; Ohi K; Tsujimoto T; Takahashi K; Takahashi S
    Psychoneuroendocrinology; 1988; 13(5):431-40. PubMed ID: 2849777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential therapeutic experiments with antidepressive efficacious psychopharmacotics].
    Luthe R; Schmitt W
    Fortschr Neurol Psychiatr Grenzgeb; 1967 Jul; 35(7):381-7. PubMed ID: 5182435
    [No Abstract]   [Full Text] [Related]  

  • 16. Family practice management of depression: how to select tricyclic antidepressants.
    Simmons EC
    South Med J; 1979 Jun; 72(6):703-4. PubMed ID: 451657
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma level monitoring of tricyclic antidepressant therapy.
    Gram LF
    Clin Pharmacokinet; 1977; 2(4):237-51. PubMed ID: 332426
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethasone suppression test as a predictor of drug treatment response.
    Arató M; Rihmer Z; Szádóczky E; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):649-52. PubMed ID: 6152343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dexamethasone test: suppressors and non-suppressors, what's the difference?].
    Vandel S; Bonin B; Vandel B; Allers G; Volmat R
    Encephale; 1985; 11(4):157-62. PubMed ID: 2935387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
    Marshall JB; Forker AD
    Am Heart J; 1982 Mar; 103(3):401-14. PubMed ID: 7039280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.